journal article·2018-04

Electroconductive Biohybrid Collagen/Pristine Graphene Composite Biomaterials with Enhanced Biological Activity

Alan J. Ryan, Cathal J. Kearney, Nian Shen, Umar Khan, Adam G. Kelly, Christopher Probst, Eva Brauchle, Sonia Biccai, Carolina D. Garciarena, Victor Vega‐Mayoral, Peter Loskill, Steve W. Kerrigan, Daniel J. Kelly, Katja Schenke‐Layland, Jonathan N. Coleman, Fergal J. O'Brien

Advanced Materials· Volume 30· Issue 15
Publisher page

Abstract

Abstract Electroconductive substrates are emerging as promising functional materials for biomedical applications. Here, the development of biohybrids of collagen and pristine graphene that effectively harness both the biofunctionality of the protein component and the increased stiffness and enhanced electrical conductivity (matching native cardiac tissue) obtainable with pristine graphene is reported. As well as improving substrate physical properties, the addition of pristine graphene also enhances human cardiac fibroblast growth while simultaneously inhibiting bacterial attachment (Staphylococcus aureus). When embryonic‐stem‐cell‐derived cardiomyocytes (ESC‐CMs) are cultured on the substrates, biohybrids containing 32 wt% graphene significantly increase metabolic activity and cross‐striated sarcomeric structures, indicative of the improved substrate suitability. By then applying electrical stimulation to these conductive biohybrid substrates, an enhancement of the alignment and maturation of the ESC‐CMs is achieved. While this in vitro work has clearly shown the potential of these materials to be translated for cardiac applications, it is proposed that these graphene‐based biohybrid platforms have potential for a myriad of other applications—particularly in electrically sensitive tissues, such as neural and neural and musculoskeletal tissues.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tissue Engineering Research Group (TERG) Department of Anatomy School of Pharmacy and Department of MCT Royal College of Surgeons in Ireland Dublin 2 Ireland

Advanced Materials and Bioengineering Research (AMBER) Centre Trinity College Dublin Ireland and Royal College of Surgeons in Ireland Dublin 2 Ireland

Trinity Centre for Bioengineering (TCBE) Trinity College Dublin Ireland

Department of Women's Health Research Institute for Women's Health Eberhard‐Karls‐University Tübingen 72076 Tübingen Germany

Department of Life Sciences PEM Centre School of Science Sligo Institute of Technology Sligo Ash Lane Sligo Ireland

Department of Cell and Tissue Engineering Fraunhofer‐Institute for Interfacial Engineering and Biotechnology (IGB) 70569 Stuttgart Germany

Department of Medicine/Cardiology Cardiovascular Research Laboratories David Geffen School of Medicine at UCLA Los Angeles CA 90095 USA

Funding

Science Foundation Ireland

References (35)

Show source-provided references
1. 10.1021/acs.biomac.7b0074910.1021/acs.biomac.7b00749 ↗
2. 10.1021/acsnano.5b0564710.1021/acsnano.5b05647 ↗
3. 10.1161/CIRCULATIONAHA.114.01493710.1161/CIRCULATIONAHA.114.014937 ↗
4. 10.1038/nnano.2011.16010.1038/nnano.2011.160 ↗
5. 10.1016/j.colsurfb.2013.05.02210.1016/j.colsurfb.2013.05.022 ↗
6. 10.1155/2014/21214910.1155/2014/212149 ↗
7. 10.1021/acsnano.6b0013010.1021/acsnano.6b00130 ↗
8. 10.1016/j.bbrc.2014.08.06210.1016/j.bbrc.2014.08.062 ↗
9. 10.1002/adem.20170062710.1002/adem.201700627 ↗
10. 10.1038/nnano.2008.21510.1038/nnano.2008.215 ↗
11. 10.1016/0021-9290(93)90030-I10.1016/0021-9290(93)90030-I ↗
12. 10.1021/acsami.5b1082910.1021/acsami.5b10829 ↗
13. 10.1039/c3ra46218h10.1039/c3ra46218h ↗
14. 10.1088/0031-9155/54/16/00210.1088/0031-9155/54/16/002 ↗
15. 10.1109/10.99568610.1109/10.995686 ↗
16. Stout D. A. · Int. J. Nanomed. · 2012 · 7 · 5653
17. 10.1016/S0142-9612(03)00471-X10.1016/S0142-9612(03)00471-X ↗
18. 10.1088/0953-8984/22/19/19411610.1088/0953-8984/22/19/194116 ↗
19. 10.1016/j.biomaterials.2009.09.08110.1016/j.biomaterials.2009.09.081 ↗
20. 10.1088/0957-4484/23/39/39510110.1088/0957-4484/23/39/395101 ↗
21. 10.1016/j.jnoncrysol.2011.11.00710.1016/j.jnoncrysol.2011.11.007 ↗
22. J.Conroy N. K.Verma R. J.Smith E.Rezvani G. S.Duesberg J. N.Coleman Y.Volkov 2014 arXiv: 1406.2497 [q‐bio.CB].
23. 10.1016/j.yjmcc.2014.05.00910.1016/j.yjmcc.2014.05.009 ↗
24. 10.1007/s12265-013-9510-z10.1007/s12265-013-9510-z ↗
25. 10.1038/nprot.2008.18310.1038/nprot.2008.183 ↗
26. 10.1016/j.stemcr.2015.12.00710.1016/j.stemcr.2015.12.007 ↗
27. 10.1021/ac801665m10.1021/ac801665m ↗
28. 10.1039/c3mb25556e10.1039/c3mb25556e ↗
29. 10.1039/C5RA06629H10.1039/C5RA06629H ↗
30. 10.1016/j.carbon.2010.07.00810.1016/j.carbon.2010.07.008 ↗
31. 10.1016/j.carbon.2009.04.04010.1016/j.carbon.2009.04.040 ↗
32. 10.1016/j.stemcr.2017.04.02110.1016/j.stemcr.2017.04.021 ↗
33. 10.1016/j.biomaterials.2013.10.08010.1016/j.biomaterials.2013.10.080 ↗
34. 10.1111/jth.1350110.1111/jth.13501 ↗
35. 10.1016/j.biomaterials.2015.09.00310.1016/j.biomaterials.2015.09.003 ↗